iifl-logo-icon 1

Pharmaids Pharmaceuticals Ltd EGM

69.94
(-0.07%)
Mar 17, 2025|12:00:00 AM

Pharmaids Pharma CORPORATE ACTIONS

17/03/2024calendar-icon
17/03/2025calendar-icon
PurposeAnnouncement DateMeeting Date
EGM6 Jan 202431 Jan 2024
Outcome of the Board meeting held on saturday, 06 January 2024. The Board decided to convene the 01st Extra Ordinary General Meeting of the Company on Wednesday, January 31, 2024 at 11:30 A.M. through Video Conferencing (VC) / Other AudioVisual Means (OAVM), in compliance with the SEBI Circulars and MCA Circulars issued from time to time, allowing the Companies to hold the General Meeting through Video Conferencing / Other Audio-Visual Means. This is to inform that the Companys Extraordinary General Meeting is scheduled to be held on Wednesday, 31 January, 2024 at 11:30 A.M. through Video Conferencing/Other Audio Visual Means (VC/OAVM). we are attaching herewith Notice of the EGM and Explanatory Statement thereto. (As Per BSE Announcement Dated on 08/01/2024) Newspaper Advertisement of Notice of 01st Extraordinary General Meeting for the Financial year 2023-24 to be held on Wednesday, 31st January 2024, along with E-voting facility and cut-off date. (As per BSE Announcement Dated on 09/01/2024) EGM 31/01/2024 (As Per BSE Bulletin Dated on 18.01.2024) Proceedings of the Extraordinary general meeting held on 31st January 2024 at 11:30 a.m. through VC/OAVM (As Per BSE Announcement Dated on 31/01/2024) Voting results along with scrutiniser report of the 01st Extraordinary General Meeting for the Financial Year 2023-24 held on Wednesday, 31st January 2024 at 11:30 A.M. thorugh VC/OAVM. (As Per BSE Announcement Dated on 02/02/2024) This is to inform you that the shareholders of the company in their Extraordinary General Meeting held on Wednesday, 31st January 2024, approved the appointment of Dr. Shankarappa Nagaraja Vinaya Babu (DIN: 01373832) as Director and Chairman (Non executive & Non Independent Category) of the company. Intimation of Alteration in Object Clause and Capital Clause of the Memorandum of Association of the Company. (As Per BSE Announcement Dated on 09/02/2024)

Pharmaids Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.